Active ingredient: trastuzumab.
Dosage preparations: 150 mg single-dose vials, and 440 mg multidose vials containing powder for concentrate for solution for infusion. Reconstituted trastuzumab concentrate contains 21 mg/ml of trastuzumab.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education